PL3082762T3 - Kompozycje ketoprofenowe o długim działaniu - Google Patents

Kompozycje ketoprofenowe o długim działaniu

Info

Publication number
PL3082762T3
PL3082762T3 PL14827320T PL14827320T PL3082762T3 PL 3082762 T3 PL3082762 T3 PL 3082762T3 PL 14827320 T PL14827320 T PL 14827320T PL 14827320 T PL14827320 T PL 14827320T PL 3082762 T3 PL3082762 T3 PL 3082762T3
Authority
PL
Poland
Prior art keywords
long
ketoprofen compositions
acting
acting ketoprofen
compositions
Prior art date
Application number
PL14827320T
Other languages
English (en)
Inventor
Richard Andrew Ewin
Steven X. Hu
Susan M. Machkovech
Barton H. Manning
Stephen Lee Secreast
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52347413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3082762(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL3082762T3 publication Critical patent/PL3082762T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL14827320T 2013-12-16 2014-12-15 Kompozycje ketoprofenowe o długim działaniu PL3082762T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361916462P 2013-12-16 2013-12-16
PCT/US2014/070336 WO2015095045A1 (en) 2013-12-16 2014-12-15 Long-acting ketoprofen compositions
EP14827320.4A EP3082762B1 (en) 2013-12-16 2014-12-15 Long-acting ketoprofen compositions

Publications (1)

Publication Number Publication Date
PL3082762T3 true PL3082762T3 (pl) 2022-02-14

Family

ID=52347413

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14827320T PL3082762T3 (pl) 2013-12-16 2014-12-15 Kompozycje ketoprofenowe o długim działaniu

Country Status (16)

Country Link
US (1) US10632095B2 (pl)
EP (1) EP3082762B1 (pl)
JP (2) JP6306188B2 (pl)
KR (1) KR101817028B1 (pl)
CN (2) CN105848638A (pl)
AU (1) AU2014366221C1 (pl)
CA (1) CA2931858C (pl)
CL (1) CL2016001350A1 (pl)
DK (1) DK3082762T3 (pl)
ES (1) ES2901706T3 (pl)
MX (1) MX373714B (pl)
NZ (1) NZ719783A (pl)
PH (1) PH12016500910A1 (pl)
PL (1) PL3082762T3 (pl)
RU (1) RU2646829C1 (pl)
WO (1) WO2015095045A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646829C1 (ru) * 2013-12-16 2018-03-07 ЗОИТИС СЕРВИСЕЗ ЭлЭлСи Композиции длительного действия на основе кетопрофена
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
EP3723729B8 (en) * 2017-12-11 2023-11-01 Meat & Livestock Australia Limited Transdermal analgesic formulation
CA3109932A1 (en) * 2018-08-24 2020-02-27 Centrexion Therapeutics Corporation Capsaicin sequential dosing method for treatment of knee joint pain
CN115252625B (zh) * 2022-08-11 2024-01-26 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种环维黄杨星d在制备治疗非洲猪瘟的制剂中的应用
KR102798067B1 (ko) * 2023-11-07 2025-04-23 주식회사 삼양애니팜 아목시실린을 포함하는 반려동물용 지속형 항생제 및 이의 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1709232A (en) * 1927-12-19 1929-04-16 James J Richardson Steering mechanism
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US4560785A (en) 1983-03-02 1985-12-24 Ss Pharmaceutical Co., Ltd. Phenylacetic ester derivatives and process for preparing the same
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US6217911B1 (en) * 1995-05-22 2001-04-17 The United States Of America As Represented By The Secretary Of The Army sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
GB9118149D0 (en) * 1991-08-22 1991-10-09 Enzymatix Ltd Araylalkanoic acid resolution
KR100499438B1 (ko) * 1997-12-03 2005-07-07 머크 앤드 캄파니 인코포레이티드 수소화 피마자유를 함유하는 지속성 주사제
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
CN1709232A (zh) * 2005-06-15 2005-12-21 沈阳药科大学 含有酮洛芬或酮洛芬酯的注射用脂质微球及其制备工艺
JP2010508289A (ja) * 2006-10-27 2010-03-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド ケトプロフェン極性誘導体の経皮的送達
US20100125060A1 (en) * 2008-11-19 2010-05-20 Majid Razzak Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
FR2950533B1 (fr) 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
CN102648897A (zh) * 2012-04-28 2012-08-29 东华大学 一种酮洛芬高分子前药聚合物微球及其制备方法
RU2646829C1 (ru) * 2013-12-16 2018-03-07 ЗОИТИС СЕРВИСЕЗ ЭлЭлСи Композиции длительного действия на основе кетопрофена

Also Published As

Publication number Publication date
PH12016500910A1 (en) 2016-06-20
NZ719783A (en) 2017-01-27
US20160303065A1 (en) 2016-10-20
US10632095B2 (en) 2020-04-28
CA2931858A1 (en) 2015-06-25
EP3082762B1 (en) 2021-11-17
BR112016012235A8 (pt) 2018-01-30
KR101817028B1 (ko) 2018-01-09
JP2016539997A (ja) 2016-12-22
CN112843042A (zh) 2021-05-28
RU2646829C1 (ru) 2018-03-07
CN105848638A (zh) 2016-08-10
AU2014366221B2 (en) 2019-06-13
WO2015095045A1 (en) 2015-06-25
DK3082762T3 (da) 2021-12-06
CL2016001350A1 (es) 2016-11-25
MX373714B (es) 2020-05-08
ES2901706T3 (es) 2022-03-23
EP3082762A1 (en) 2016-10-26
RU2016121639A (ru) 2018-01-23
CA2931858C (en) 2018-12-11
JP6306188B2 (ja) 2018-04-04
AU2014366221A1 (en) 2016-05-26
BR112016012235A2 (pt) 2017-08-08
AU2014366221C1 (en) 2019-10-03
KR20160078491A (ko) 2016-07-04
MX2016007869A (es) 2016-10-07
JP2018058880A (ja) 2018-04-12

Similar Documents

Publication Publication Date Title
LT3052080T (lt) Ilgo veikimo spiro-izoksazolino vaistinės formos
GB201304662D0 (en) Compositions
PL3065569T3 (pl) Kompozycja
SI2970336T1 (sl) Spojine tetrahidropirolotiazina
GB201313615D0 (en) Compositions
PT3027750T (pt) Composição biocatalítica
GB201318489D0 (en) Composition
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201319540D0 (en) Composition
GB201320303D0 (en) Composition
GB201320919D0 (en) Composition
GB201317388D0 (en) Composition
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
GB201322772D0 (en) Composition
GB201317196D0 (en) Composition
DK3082762T3 (da) Langtidsvirkende ketoprofensammensætninger
GB201307622D0 (en) Composition
ZA201505650B (en) New compositions
GB201320962D0 (en) Compositions
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201305622D0 (en) Composition